Trexquant Investment’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Trexquant Investment’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-4,300	Closed	-$462K	–	1478
2016 Q4	$462K	Buy	+4,300	New	+$503K	0.07%	479
2015 Q4	–	Sell	-3,600	Closed	-$323K	–	1426
2015 Q3	$323K	Buy	+3,600	New	+$380K	0.03%	859
2015 Q1	–	Sell	-3,100	Closed	-$208K	–	1321
2014 Q4	$208K	Buy	+3,100	New	+$192K	0.04%	801

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

HIM

Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Trexquant Investment's CBPO Position: Q1 2017 in Review

Trexquant Investment sold out of China Biologic Products Holdings, Inc. (CBPO) in Q1 2017, closing a stake of 4,300 shares — an estimated $462K sold.

Trexquant Investment first reported a position in CBPO in Q4 2014 and held it in 3 quarters. The position peaked at $462K in Q4 2016. 137 funds tracked by Wall St. Rank hold CBPO as of Q1 2017.

Trexquant Investment reported no remaining China Biologic Products Holdings, Inc. position as of Q1 2017 after selling out during the quarter.
Trexquant Investment sold 4,300 China Biologic Products Holdings, Inc. shares in Q1 2017, an estimated $462K.
Trexquant Investment first reported a position in China Biologic Products Holdings, Inc. in Q4 2014 and held it in 3 quarters.
Trexquant Investment's China Biologic Products Holdings, Inc. position peaked at $462K in Q4 2016.
137 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q1 2017.

Based on Trexquant Investment's 13F filing for Q1 2017, filed 9 May 2017.